Chapter 4 Cultural, Legal, & Ethical Considerations
Download
Report
Transcript Chapter 4 Cultural, Legal, & Ethical Considerations
Schedule I – Only w/ approved protocol
▪ Heroin, marijuana
Schedule II – Written rx only, no refills
▪ Codeine, morphine, methadone, oxycontin, ritalin, dilaudid
Schedule III – Written rx or oral rx, 5 refills in 6
month period, container must have warning
* Tylenol w/ codeine, testosterone
Schedule IV – Written or oral rx, 5 refills
▪ Benzodiazepines (valium, xanax); Ambien
Schedule V – Written rx or OTC
▪ Cough/cold meds (Robitussin AC); Lomotil
1. Preclinical testing
▪ 3 ½ years
▪ Lab & animal research (rats)
▪ Drug evaluated for safety
2. Investigational New Drug Application
▪ Drug company files IND with FDA
▪ Must be approved or disapproved by FDA within 30 days
3. Clinical Trials
▪ Phase I
▪ 1 year, 20-80 healthy volunteers (no disease)
▪ Study of a drug’s safety profile & safe dosage
▪ Studies Pharmacokinetics (absorption, distrib, metab, excretion)
Phase II
▪ Controlled studies of 100-300 volunteers (people with
disease)
▪ To assess drug effectiveness and safe dosage, 2 years
Phase III
▪ 3 years
▪ Involves 1000-3000 patients in clinics & hospitals
▪ Use of placebo
▪ Physicians closely monitor all patients to determine
safety, efficacy, and adverse reactions
Phase IV
2 years, post-release of drug
To further assess therapeutic & adverse effects
Black Box Warning: placed on drug by FDA if
severe reactions are occurring
▪ ie: Advair, Accutane
4. New drug application
Follows completions of all 3 clinical trials
Report of all scientific data (100 pages)
FDA has 6 months to review and approve
Final approval: New drug available to physicians to
prescribe
Drug company must submit periodic reports to FDA
$12 billion in drug research and development per year,
rising
Native American
▪ Harmony w/ nature, evil spirits cause disease
Asian
▪ Traditional medicine, herbal remedies
African
▪ Folk medicine, “healers”
Western
▪ Prevention of disease, education, medications
Hispanic
▪ Health = good luck, Illness = bad luck, bad deed
▪ Heat and cold remedies instead of medicines
HEPARIN
Classification: Anticoagulant, Antithrombotic
Action: Prevents conversion of prothrombin
to thrombin, prevents thrombus formation
Indications: To prevent & treat
thromboembolism and PE; also used to
maintain IV catheter patency (in low doses)
Contraindications: bleeding,
thrombocytopenia, severe liver disease
HEPARIN (continued)
Adverse Effects: bleeding, anemia, pain at
injection site
Route: IV or subcutaneous; administer in
abdominal tissue
Dosage: 5,000 units q 8-12 hr. (subcut)
Nursing Implications:
Assess for S/S bleeding (gums, nose, bruising,
black stools, hematuria)
HEPARIN (continued)
Assess injection site for hematoma, ecchymosis
Monitor PTT, Hg, Hct, Platelets
**Antidote = Protamine Sulfate
Refer to Davis Drug Guide for Nurses
Heparin
Absorption: Quickly absorbed after injection
Distribution: Does not cross placenta or enter breast
milk, Highly bound to proteins
Metabolism: probably metabolized by lymph system
and spleen, unknown
Excretion: removed by lymph system and spleen
½ life: 1-2 hour, dependent upon dosage
Onset: 20-60 min.
Peak: 2 hrs
Duration: 8-12 hrs.
Warfarin (Coumadin)
Classification: Anticoagulant
Indication: Prevention and treatment of
venous thrombosis, PE, DVT, atrial
fibrillation, MI
Common SE: Bleeding, nausea, fever
Route: *Oral, IV
Dosage: Oral – 2.5 – 10mg daily
Nursing Interventions:
Assess for signs of bleeding
Monitor PT/INR, CBC
Patients >60 may have greater than expected INR
High Alert medication
3-5 days to reach effective levels
Instruct pt. to take med. at same time, evening
Avoid foods high in Vitamin K
Avoid Aspirin containing products and alcohol
MEDICATION NAME
(Generic, Trade Names)
CLASSIFICATION
ROUTE OF ADMINISTRATION
DOSAGE
INDICATION/THERAPEUTIC
USE
COMMON SIDE EFFECTS (LIST 3-4)
NURSING INTERVENTIONS
Humalog
Novolog
Humulin R
Novolin R
NPH
Lantus, Levimir
Humalog
▪ Cheaper ?
Novolog
▪ Stronger ?
Humulin
Novolin
Rapid acting
Humalog, Novolog
Short acting
Humulin R, Novolin R
Intermediate acting
NPH
Long acting
Lantus, Levemir
Sliding Scale
Insulin Sensitivity Factor
▪ Blood glucose minus target glucose (140) divided by ISF (40)
Carbohydrate Coverage
▪ 1:10
▪ 1:15
▪ 1:20
Cheerios
8 oz. skim milk
2 slices toast
Butter
4 oz. cranberry juice
Coffee 10 oz.
Splenda
20 gm.
5 gm.
24 gm.
0 gm.
6 gm.
0 gm.
0 gm.